Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully hosted the 2025 Small Nucleic Acid Therapeutics Roundtable on July 26 in Beijing. The event convened ...

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

PharmaJet Tropis is now the exclusive intradermal delivery system for two novel Covid-19 vaccines in India. It has been used for millions of injections in multiple immunization campaigns worldwide.

The nucleic acid delivery market is maturing with over 1,450 clinical trials underway worldwide. The majority of these are in early clinical development (approximately 60%) with just over 3% in ...

Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach. Biomacromolecules, 2024; DOI: 10.1021/acs ...

Study: Nucleic acid delivery and nanoparticle design for COVID vaccines. Image Credit: Love Employee / Shutterstock.com. Introduction. Nucleic acid therapeutics can harness the potential of ...

Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.

Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work By Nick Paul Taylor Jan 24, 2023 6:30am AstraZeneca University of Oxford anti-sense oligo messenger RNA ...

Just a few short months after the biotech’s nucleic acid delivery tech helped land a deal with BioMarin, the Edmonton, Alberta-based Canadian company has teamed up with Eli Lilly for $50 million ...

Eli Lilly and Company has acquired exclusive rights to Entos Pharmaceuticals’ nucleic acid delivery technology for $50 million. As part of the deal, Entos will create proteolipid vehicles for ...

Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways BEIJING, July 29, 2025 /PRNewswire/ -- Tsingke Biotech, a leading provider ...

Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver ...